Skip to search formSkip to main contentSkip to account menu

Doxercalciferol

Known as: 1-alpha-hydroxyvitamin D2, 1?-Hydroxyergocalciferol, 1 alpha-hydroxyergocalciferol 
A synthetic analog of vitamin D with potential antineoplastic activity. In the liver, doxercalciferol is converted to its biologically active vitamin… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Objective To review the inter-relationships between calcium, phosphorus, parathyroid hormone (PTH), parent and activated vitamin… 
Highly Cited
2011
Highly Cited
2011
We compared the effects of calcitriol and doxercalciferol, in combination with either calcium carbonate or sevelamer, on bone… 
Highly Cited
2010
Highly Cited
2010
BACKGROUND AND OBJECTIVES The optimal treatment of secondary hyperparathyroidism in chronic kidney disease (CKD) is unknown… 
Highly Cited
2010
Highly Cited
2010
Dietary phosphorus control is often a main strategy in the management of patients with chronic kidney disease. Dietary protein is… 
Highly Cited
2010
Review
2010
Review
2010
Vitamin D deficiency is prevalent among patients with end-stage organ failure awaiting transplant. Low serum 25-hydroxyvitamin D… 
Highly Cited
2006
Highly Cited
2006
Intravenous vitamin D is standard therapy for secondary hyperparathyroidism in hemodialysis (HD) patients. In for-profit dialysis… 
Highly Cited
2004
Highly Cited
2004
BACKGROUND Calcitriol lowers parathyroid hormone (PTH) levels in patients with chronic kidney disease (CKD) stages 3 and 4, but… 
Highly Cited
2001
Highly Cited
2001
Most reports on the effectiveness and side effects of oral versus parenteral calcitriol or alfacalcidol in hemodialysis patients… 
Highly Cited
2000
Highly Cited
2000
Abstract Hypercalcemia and hyperphosphatemia frequently necessitate vitamin D withdrawal in hemodialysis patients with secondary…